Skip to main content
. 2009 Sep 2;29(35):10869–10882. doi: 10.1523/JNEUROSCI.5531-08.2009

Figure 1.

Figure 1.

Generation of Grin2b-flox and Grik4-Cre mice. A, Schematic representations of GluK4 cDNA, genomic DNA (Grik4wt), and targeted genome (Grik4Cre). The gray boxes indicate exons. The black boxes indicate the probes for Southern blot analysis. The filled circles in the Grik4Cre allele delineate the 5′ and 3′ termini of the targeting vector. The semicircles indicate FRT sequences. Met, Initial methionine; Cre, Cre recombinase gene; neo, neomycin-resistant gene expression cassette; Xb, XbaI; ET, EcoT22-I. B, Southern blot analysis of XbaI- or EcoT22-I-digested genomic DNA prepared from the wild-type (Grik4+/+) and heterozygous Cre (Grik4Cre/+) mice. C, β-Galactosidase activity induced by Grik4-Cre in 4-week-old reporter mice. a, β-Galactosidase staining of a whole-brain slice (50 μm thick). b, c, Hippocampus, counterstained with nuclear fast red (NFR) (b) or reacted with anti-calbindin antibody (c). d, e, CA3 region. Parvalbumin (d) and glutamine synthase (e) were stained with respective antibodies as markers for interneurons and glial cells, respectively. Scale bars: a, 3 mm; b, c, 100 μm; d, e, 10 μm. D, Schematic representations of GluN2B cDNA, genomic DNA (Grin2bwt), targeted genome (Grin2bflox), and Cre-mediated deleted genome (Grin2bdel). The gray boxes indicate exons. The black boxes indicate the probes for Southern blot analysis. The triangles indicate loxP sequences. The filled circles in the Grin2bflox allele delineate the 5′ and 3′ termini of the targeting vector. Nh, NheI; Nd, NdeI. E, Southern blot analysis of NdeI- or NheI-digested genomic DNA prepared from the wild-type (Grin2b+/+), heterozygous floxed (Grin2b+/flox), homozygous floxed (Grin2bflox/flox), and heterozygous floxed and deleted (Grin2bflox/del) mice. F, Immunoblot analysis of whole-brain crude fraction prepared from the wild-type, heterozygous (Grin2b+/flox), and homozygous floxed (Grin2bflox/flox) mice at P0.5 with anti-GluN2BC and anti-NSE antibodies.